Patrick A. Cosgrove

500 total citations
19 papers, 320 citations indexed

About

Patrick A. Cosgrove is a scholar working on Molecular Biology, Oncology and Aerospace Engineering. According to data from OpenAlex, Patrick A. Cosgrove has authored 19 papers receiving a total of 320 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Oncology and 4 papers in Aerospace Engineering. Recurrent topics in Patrick A. Cosgrove's work include Single-cell and spatial transcriptomics (4 papers), Cancer Genomics and Diagnostics (4 papers) and Advanced Breast Cancer Therapies (3 papers). Patrick A. Cosgrove is often cited by papers focused on Single-cell and spatial transcriptomics (4 papers), Cancer Genomics and Diagnostics (4 papers) and Advanced Breast Cancer Therapies (3 papers). Patrick A. Cosgrove collaborates with scholars based in United States, China and Australia. Patrick A. Cosgrove's co-authors include Andrea H. Bild, Jeffrey T. Chang, Helen J. McBride, Robert T. Dunn, Cynthia A. Afshari, Hisham K. Hamadeh, Donna B. Stolz, Linda G. Griffith, Philip J. Moos and Aritro Nath and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and eLife.

In The Last Decade

Patrick A. Cosgrove

17 papers receiving 312 citations

Peers

Patrick A. Cosgrove

ONCOL

IMMUN

Brandon Cooper United States

Linmao Sun China

Chuanhai Zhang China

Yuta Okumura Japan

Martina Torchio Italy

Thomas Pöschinger Germany

Pablo Zoroquiaín Canada

Juying Zhou China

Deepak Raina India

Brandon Cooper United States

Patrick A. Cosgrove

112 ×0.9

113 ×0.9

ONCOL

100 ×1.4

17 ×0.3

IMMUN

55 ×1.0

Citations per year, relative to Patrick A. Cosgrove Patrick A. Cosgrove (= 1×) peers Brandon Cooper

Countries citing papers authored by Patrick A. Cosgrove

Since Specialization

Citations

This map shows the geographic impact of Patrick A. Cosgrove's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick A. Cosgrove with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick A. Cosgrove more than expected).

Fields of papers citing papers by Patrick A. Cosgrove

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick A. Cosgrove. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick A. Cosgrove. The network helps show where Patrick A. Cosgrove may publish in the future.

Co-authorship network of co-authors of Patrick A. Cosgrove

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick A. Cosgrove. A scholar is included among the top collaborators of Patrick A. Cosgrove based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick A. Cosgrove. Patrick A. Cosgrove is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Griffiths, Jason I., Feng Chi, Elena Farmaki, et al.. (2025). Blocking cancer-fibroblast mutualism inhibits proliferation of endocrine therapy resistant breast cancer. Molecular Systems Biology. 21(7). 825–855.

Griffiths, Jason I., Patrick A. Cosgrove, Aritro Nath, et al.. (2025). Cellular interactions within the immune microenvironment underpins resistance to cell cycle inhibition in breast cancers. Nature Communications. 16(1). 2132–2132. 4 indexed citations

Cosgrove, Patrick A., et al.. (2024). Single-Cell Transcriptomics Sheds Light on Tumor Evolution: Perspectives from City of Hope’s Clinical Trial Teams. Journal of Clinical Medicine. 13(24). 7507–7507. 2 indexed citations

Farmaki, Elena, et al.. (2023). ONC201/TIC10 enhances durability of mTOR inhibitor everolimus in metastatic ER+ breast cancer. eLife. 12. 7 indexed citations

Liu, Shunan, Leying Zhang, Hang Gao, et al.. (2022). RAGE Inhibitors as Alternatives to Dexamethasone for Managing Cerebral Edema Following Brain Tumor Surgery. Neurotherapeutics. 19(2). 635–648. 8 indexed citations

Nath, Aritro, Patrick A. Cosgrove, Jeffrey T. Chang, & Andrea Bild. (2022). Predicting clinical response to everolimus in ER+ breast cancers using machine-learning. Frontiers in Molecular Biosciences. 9. 981962–981962. 6 indexed citations

Griffiths, Jason I., Jinfeng Chen, Patrick A. Cosgrove, et al.. (2021). Serial single-cell genomics reveals convergent subclonal evolution of resistance as patients with early-stage breast cancer progress on endocrine plus CDK4/6 therapy. Nature Cancer. 2(6). 658–671. 41 indexed citations

Nath, Aritro, Patrick A. Cosgrove, Elizabeth L. Christie, et al.. (2021). Evolution of core archetypal phenotypes in progressive high grade serous ovarian cancer. Nature Communications. 12(1). 3039–3039. 31 indexed citations

Moses, Robert W., et al.. (2021). Protecting Crew and Surface Systems with a Long-Duration Lunar Safe Haven. 5 indexed citations

10.

Grolmusz, Vince Kornél, Jinfeng Chen, Patrick A. Cosgrove, et al.. (2020). Exploiting collateral sensitivity controls growth of mixed culture of sensitive and resistant cells and decreases selection for resistant cells in a cell line model. Cancer Cell International. 20(1). 253–253. 17 indexed citations

11.

Griffiths, Jason I., Pierre Wallet, Lance Pflieger, et al.. (2020). Circulating immune cell phenotype dynamics reflect the strength of tumor–immune cell interactions in patients during immunotherapy. Proceedings of the National Academy of Sciences. 117(27). 16072–16082. 67 indexed citations

12.

Chi, Feng, Jiayi Liu, Samuel W. Brady, et al.. (2020). A `one-two punch' therapy strategy to target chemoresistance in estrogen receptor positive breast cancer. Translational Oncology. 14(1). 100946–100946. 12 indexed citations

13.

Cosgrove, Patrick A., Robert T. Dunn, Donna B. Stolz, et al.. (2016). Modeling Therapeutic Antibody–Small Molecule Drug-Drug Interactions Using a Three-Dimensional Perfusable Human Liver Coculture Platform. Drug Metabolism and Disposition. 44(12). 1940–1948. 76 indexed citations

14.

Helmering, Joan, Todd Juan, Tibor Gyuris, et al.. (2014). A mutation in Ampd2 is associated with nephrotic syndrome and hypercholesterolemia in mice. Lipids in Health and Disease. 13(1). 167–167. 12 indexed citations

15.

Wright, H. Stephen, Mark A. Croom, Robert D. Braun, et al.. (2003). ARES Mission Overview - Capabilities and Requirements of the Robotic Aerial Platform. 25 indexed citations

16.

Dixon, Iain R., et al.. (1993). A conceptual design study for a two-dimensional, electronically scanned thinned array radiometer. 4 indexed citations

17.

Cosgrove, Patrick A., et al.. (1990). Thermal-distortion analysis of a spacecraft box truss in geostationary orbit. NASA Technical Reports Server (NASA). 1 indexed citations

18.

Cosgrove, Patrick A., Dorothy L. Patton, C C Kuo, San-Pin Wang, & Thomas D. Lindquist. (1989). Experimentally induced ocular chlamydial infection in infant pig-tailed macaques.. PubMed. 30(5). 995–1003.

19.

Patton, Dorothy L., et al.. (1987). Experimental trachoma in subcutaneous conjunctival autografts in macaques.. PubMed. 28(9). 1575–82. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact